75000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Parenthetical) [Default]
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity (Unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75070 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75080 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Nature of the Business and Basis of Presentation
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Reverse Recapitalization and Pre-Closing Financing
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Fair Value Measurements
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Discontinued Operations
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Other Investment
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Property and Equipment
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Accrued Expenses and Other Current Liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Convertible Preferred Stock and Stockholders' Equity (Deficit)
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Stock-Based Compensation
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Income Taxes
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Paragon Agreements
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Leases
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Net Loss per Share
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Option/License Agreement
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Segment Reporting
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Summary of Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Reverse Recapitalization and Pre-Closing Financing (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Fair Value Measurements (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Convertible Preferred Stock and Stockholders' Equity (Deficit) (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Stock-Based Compensation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Leases (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Net Loss per Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Segment Reporting (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Nature of the Business and Basis of Presentation (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Summary of Significant Accounting Policies - Cash, Cash Equivalents, and Restricted Cash (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Summary of Significant Accounting Policies -Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Reverse Recapitalization and Pre-Closing Financing - Schedule of the Assets and Assumed the Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Fair Value Measurements (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Fair Value Measurements - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of accrued expenses and other current liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of accrued expenses and other current liabilities (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Convertible Preferred Stock and Stockholders' Equity (Deficit) - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Convertible Preferred Stock and Stockholders' Equity (Deficit) - Common Stock Reserved For Future Issuance (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Stock-Based Compensation - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Stock-Based Compensation - Additional Information (Details) [Default]
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Stock-Based Compensation - Additional Information1 (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Stock-Based Compensation - Additional Information1 (Details) [Default]
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used in Calculating the Fair Value (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Stock-Based Compensation - Summary of RSA Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) [Default]
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Income Taxes - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Paragon Agreements - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Leases - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Leases - Schedule of Total Remaining Operating Lease Payments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - Leases - Schedule of Total Remaining Operating Lease Payments (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Commitments and Contingencies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995965 - Disclosure - Net Loss per Share - Schedule of Basic and Diluted Earnings Per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995975 - Disclosure - Net Loss per Share - Schedule of Basic and Diluted Earnings Per Share (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
995985 - Disclosure - Net Loss per Share - Schedule of Basic and Diluted Earnings Per Share (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995995 - Disclosure - Net Loss per Share - Schedule of Anti-Dilutive Effect Excluded from Potential Computation of Diluted Net Loss Per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996005 - Disclosure - Option/License Agreement - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996015 - Disclosure - Related Party Transactions - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996025 - Disclosure - Segment Reporting - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996035 - Disclosure - Segment Reporting - Summary of the Segment Loss including Significant Segment Expenses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996045 - Disclosure - Segment Reporting - Summary of the Segment Loss including Significant Segment Expenses (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Commercialization milestone payments
Commercialization Milestone Payments
Commercialization milestone payments.
Related Party Transaction [Table]
Upfront license fee
Collaborative Arrangement, Rights And Obligations Upfront Fee
Collaborative arrangement, rights and obligations upfront fee
Undisclosed programs research and development costs.
Undisclosed Programs Research and Development Costs
Undisclosed programs research and development costs
Common Stock, Capital Shares Reserved for Future Issuance
Shares reserved for issuance
Schedule of Accrued Liabilities [Table Text Block]
Schedule of accrued expenses and other current liabilities
Preferred Stock, Shares Issued
Preferred stock, shares issued
Total present value of operating lease liability
Operating Lease, Liability
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested
Unvested RSAs
Series Seed Convertible Preferred Stock [member]
Series seed convertible preferred stock.
Series Seed Convertible Preferred Stock
License Agreement [Abstract]
License agreement abstract.
Commitments and Contingencies
Commitments and contingencies (Note 11)
Weighted Average Number of Shares Outstanding, Diluted
Weighted Average Number of Shares Outstanding, Diluted, Total
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted
Weighted Average Shares Outstanding, Diluted
Option exercise fee
Collaboration Program, Option Exercise Fee
Collaboration program, option exercise fee.
APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Stock-based compensation
Minimum
Minimum [Member]
Minimum [Member]
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred Stock, Shares Outstanding, Ending Balance
Preferred Stock, Shares Outstanding
Preferred stock, shares outstanding
Outstanding shares
Recurring
Fair Value, Recurring [Member]
Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block]
Schedule of the assets and assumed the liabilities
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage
Percentage of vesting
Consolidated Entities
Consolidated Entities [Domain]
Common Stock, Shares, Issued, Total
Common stock, shares issued
Common Stock, Shares, Issued
Segment Reporting [Line Items]
Income tax provision
Income Tax Expense (Benefit)
Income Tax Expense (Benefit), Total
Interest income
Other Nonoperating Income
Pre-Merger Korsana [Member]
Pre-merger Korsana.
Pre-Merger Korsana
Related Party Transaction [Line Items]
Medsteer Collaboration Agreement [Member]
Medsteer Collaboration Agreement [Member]
Medsteer Collaboration Agreement.
Additional up front payment
Additional Up Front Payment
Additional up front payment.
Option fee
Option Fee
Option fee
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Warrants purchase for common stock
Directors' fees
Director Fee
Operating Segments [Member]
Operating Segments
Stock Issued During Period, Value, Conversion of Convertible Securities
Stock Issued During Period, Value, Conversion of Convertible Securities
Defined Benefit Plan, Benefit Obligation, Ending Balance
Defined Benefit Plan, Benefit Obligation, Beginning Balance
Defined Benefit Plan, Benefit Obligation
Separation benefits obligation
Less: Imputed interest
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Issuance of common stock to former shareholders of Cyclerion in connection with the closing of the reverse recapitalization
Stock Issued During Period Value Acquisition
Stock issued during period value acquisition.
Property and Equipment
Property, Plant and Equipment Disclosure [Text Block]
Nonoperating Income (Expense)
Interest income
Total other income
Reclassified from liability to equity
Proceeds for Unvested Restricted Stock Awards Reclassified from Liability to Equity
Proceeds for unvested RSA reclassified from liability to equity.
Costs and Expenses, Related Party
Realted party amount
Shares increase percentage
Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum
General and Administrative Expense, Total
General and administrative
General and Administrative Expense
Income Statement [Abstract]
Forfeited (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Forfeited (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
Number of share options granted
Accrued Expenses and Other Current Liabilities [Line Items]
Accrued Expenses and Other Current Liabilities.
Related Party
Related and Nonrelated Parties [Domain]
Earnings Per Share, Basic
Total (gain) loss per share
Net loss per share attributable to common stockholders, basic
Loss Per Share - Basic
Document Period End Date
Document Period End Date
Series B Preferred Stock [Member]
Series B Preferred Stock
Collaborative Arrangement Expense Recognized
Collaborative arrangement expense recognized.
Expense recognized
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
Award expiration period
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment, Total
Purchases of property and equipment
Purchases of property and equipment
Exercise price
Granted (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Noncash Or Part Noncash, Reverse Recapitalization Issuance Costs Included In Accounts Payable And Accrued Expenses
Pre-closing financing and reverse recapitalization issuance costs included in accounts payable and accrued expenses
Pre-Closing Financing and reverse recapitalization issuance costs included in accounts payable and accrued expenses
Common Stock, Shares Authorized
Common stock, shares authorized
Statement of Stockholders' Equity [Abstract]
Accrued Research And Development Costs Current
Accrued research and development costs current.
Accrued research and development
Prepaid expenses and other current assets
Prepaid Expense and Other Assets, Current
Accrued expenses and other current liabilities
Accrued expenses and other current liabilities
Accrued Expenses And Other Liabilities Current
Amount of accrued expenses and other liabilities current.
2026 Employee Stock Purchase Plan
Two Thousand Twenty Six Employee Stock Purchase Plan [Member]
2026 employee stock purchase plan.
Parasa Warrant [Member]
Parasa warrant.
Parasa Warrant Obligation
Parasa Warrant
Costs and Expenses
Costs and Expenses, Total
Expenses
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Aggregate Intrinsic Value, Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Share outstanding percentage
Shares Outstanding Percentage
Shares outstanding percentage.
Common stock no par value
Common Stock, No Par Value
Total assets
Assets
Title of 12(b) Security
Title of 12(b) Security
Exchange Ratio
Exchange Ratio [Member]
Exchange ratio.
Research Initiation Milestone
Research initiation milestone.
Research initiation milestone
Preferred Stock, Value, Issued
Preferred stock
Beginning balance
Ending balance
Related Party Transaction [Axis]
Unvested the end of the period (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Unvested as of December 31, 2021
Unvested at the beginning of the period (in shares)
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Schedule of Stock-Based Compensation Expense
Granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Title and Position [Domain]
Antidilutive Securities, Name
Antidilutive Securities, Name [Domain]
Stockholders' Equity Note, Stock Split, Conversion Ratio
Stock conversion ratio
Conversion price
Preferred Stock, Convertible, Conversion Price
Effective Income Tax Rate Reconciliation, Percent
Effective Income Tax Rate Reconciliation, Percent, Total
Effective income tax rate
2026 (remaining 3 months)
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Lessee, Operating Lease, Liability, to be Paid, Year One
2027
Location, Statement of Financial Position, Balance [Axis]
Proceeds from the Pre Closing Financing
Proceeds from the pre closing financing.
Proceeds from the Pre-Closing Financing
Cash and Cash Equivalents
Cash and Cash Equivalents [Domain]
Weighted Average Remaining Contractual Term (years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Segment Reporting [Table Text Block]
Summary of the Segment Loss including Significant Segment Expenses
Leases
Lessee, Operating Leases [Text Block]
Beginning balance
Ending balance
Equity, Attributable to Parent
Total stockholders' equity (deficit)
Entity Address, Address Line Two
Related party amount included in accrued expenses and other liabilities
Related Party Amount Included In Accrued Expenses And Other Liabilities
Related party amount included in accrued expenses and other liabilities.
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Income Tax Disclosure [Text Block]
Income Taxes
Earnings Per Share [Text Block]
Net Loss per Share
Number of Reportable Segments
Number of reportable segments
Weighted-Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Basis of Accounting, Policy [Policy Text Block]
Background and Basis of Presentation
Payment to former chief financial officer
Severance and benefits costs
Severance Costs
Related Party Amount Included In Proceeds from Pre Closing Financing
Amount included in proceeds from the Pre-Closing Financing that is attributable to related party.
Related party amount included in proceeds from the Pre-Closing Financing
Stock, Class of Stock [Table]
Schedule Of Stock By Class [Table]
AB program research and development costs
AB Program Research and Development Costs
Aβ program research and development costs.
Payment of Pre Closing Financing and Reverse Capitalization Issuance Costs
Payment of pre closing financing and reverse capitalization issuance costs.
Payment of Pre-Closing Financing and reverse recapitalization issuance costs
Restricted Stock [Member]
Restricted Stock Awards
Vested (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Korsana Biosciences Inc [Member]
Korsana Biosciences Inc.
Korsana
Accrued other liabilities, non-current
Other Accrued Liabilities, Noncurrent
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]
Statistical Measurement
Statistical Measurement [Axis]
Venrock
Venrock [Member]
Venrock.
Money market funds
Money Market Funds [Member]
Entity Interactive Data Current
Entity Interactive Data Current
Lessee, Operating Lease, Liability, to be Paid, Year Three
2029
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Weighted Average Remaining Contractual Term (years), Vested and expected to vest
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common Stock, Value, Issued, Ending Balance
Common Stock, Value, Issued, Beginning Balance
Common Stock, Value, Issued, Total
Common Stock, Value, Issued
Common stock, no par value; 700,000,000 and 122,363,552 shares authorized as of September 30, 2026 and December 31, 2025, respectively; 45,541,358 and 1,244,400 shares issued and outstanding as of September 30, 2026 and December 31, 2025
Schedule of basic and diluted earnings per share
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Business Description and Basis of Presentation [Text Block]
Nature of the Business and Basis of Presentation
Other liabilities assumed in connection with the reverse recapitalization
Noncash or Part Noncash Acquisition, Other Liabilities Assumed
Property and Equipment
Property, Plant, and Equipment [Policy Text Block]
Liabilities
Total liabilities
Akebia Material Purchase Agreement [Member]
Akebia Material Purchase Agreement.
Akebia Material Purchase Agreement [Member]
Akebia Research License Agreement [Member]
Akebia Research License Agreement [Member]
Akebia Research License Agreement Member.
Prepaid expenses and other current assets
Increase (Decrease) in Prepaid Expenses, Other
Stock options
Equity Option [Member]
Retained Earnings (Accumulated Deficit), Ending Balance
Retained Earnings (Accumulated Deficit), Beginning Balance
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Single Reportable Segment [Member[
Single reportable segment
Single Reportable Segment
Entity Bankruptcy Proceedings, Reporting Current
Convertible Preferred Stock
Convertible Preferred Stock [Member]
Level 3
Fair Value, Inputs, Level 3 [Member]
Total cash equivalents
Cash and Cash Equivalents, Fair Value Disclosure
Operating Expenses
Operating expenses
Total operating expenses
Research and development personnel costs (including stock-based compensation)
Research and Development Personnel Costs including Stock-based Compensation)
Research and development personnel costs (including stock-based compensation).
Preferred stock units converted
Stock Issued During Period, Shares, Conversion of Units
Liabilities, Noncurrent [Abstract]
Long term liabilities:
Changes in operating assets and liabilities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Award vesting period
Shares Issued, Price Per Share
Common stock share purchase price
Share price
Parasa Warrant Stock-based Compensation
Parasa warrant stock-based compensation.
Parasa warrant stock-based compensation
Stock Issued During Period, Shares, New Issues
Common stock purchased
Issuance of convertible preferred stock
Class of Warrant or Right, Outstanding
Pre-funded warrants outstanding
Pre-Funded Warrants [Member]
Pre-funded warrants.
Pre-Funded Warrants
Weighted-average number of shares of as-converted
Weighted Average Number of Shares, Contingently Issuable
Restricted cash
Restricted Cash
Restricted Cash, Total
Ending balance
Temporary Equity, Carrying Amount, Attributable to Parent
Beginning balance
Incremental borrowing rate
Incremental Borrowing Rate
Incremental borrowing rate.
Related Party Transactions [Abstract]
Long-Lived Tangible Asset
Long-Lived Tangible Asset [Axis]
Warrant Liability Related Party
Warrant liability related party.
Warrant liability, related party
Other General and Administrative Expense
Other general and administrative costs
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Axis]
Expected volatility
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Defined Benefit Plan [Table]
Assets, Fair Value Disclosure [Abstract]
Assets:
Risk-free interest rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Reclassification of Vested RSA Proceeds from Liability-Based to Equity-Based
Reclassification of vested RSA proceeds from liability-based to equity-based.
Reclassification of vested RSA proceeds from liability-based to equity-based
Additional milestone cash payment
Payment Of Cash Milestone
Payment of cash milestone.
Other Sundry Liabilities, Current
Other accrued expenses
Issuance costs
Payments of Stock Issuance Costs
Common Stock and Pre-funded Warrants
Common Stock and Pre Funded Warrants [Member]
Common Stock and pre-funded warrants.
Operating Lease, Liability, Current
Operating lease liability, current
Short term lease liabilities
Unvested restricted common stock at the end of the period (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Unvested as of December 31, 2021
Unvested at the beginning of the period (in dollars per share)
Summary of Significant Accounting Policies [Line Items]
Summary of significant accounting policies.
Liabilities and Equity
Total liabilities, convertible preferred stock and stockholders' equity (deficit)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Dividend yield
2028
Lessee, Operating Lease, Liability, to be Paid, Year Two
Research and Development Expense, Total
Research and development
Research and Development Expense
Research and development costs
Schedule of Summary of Significant Accounting Policies [Table]
Schedule of summary of significant accounting policies.
Document Fiscal Period Focus
Document Fiscal Period Focus
Schedule of Assumptions Used in Calculating the Fair Value
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Title and Position [Axis]
Issuance Costs of Pre-Closing Financing and Reverse Recapitalization Value
Issuance costs of pre-closing financing and reverse recapitalization value.
Issuance costs of Pre-Closing Financing and reverse recapitalization
Letters of Credit Outstanding, Amount
Letter of credit
2026 Stock Incentive Plan
Two Thousand Twenty Six Stock Incentive Plan [Member]
2026 stock incentive plan.
General and Administrative Personnel Costs including Stock-based Compensation
General and administrative personnel costs (including stock-based compensation).
General and administrative personnel costs (including stock-based compensation)
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Net increase in cash, cash equivalents and restricted cash
Entity Current Reporting Status
Entity Current Reporting Status
Exercisable (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Level 1
Fair Value, Inputs, Level 1 [Member]
Class of Stock [Domain]
Accounts Payable, Current, Total
Accounts payable
Accounts Payable, Current
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Anti-Dilutive Effect Excluded from Potential Computation of Diluted Net Loss Per Share
Assets, Fair Value Disclosure
Total assets
Total assets
Interest Income, Operating
Interest Income, Operating, Total
Interest income
Interest income
Document Transition Report
Document Transition Report
Series B Non-voting Convertible Preferred Stock [Member]
Series b non-voting convertible preferred stock.
Series B Non-voting Convertible Preferred Stock
Number of Votes Per Each Employee
Number of votes per each employee.
Number of votes per each employee
Commitments and Contingencies Disclosure [Abstract]
Class of Warrant or Right [Axis]
Accrued expenses and other current liabilities
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Number of operating leases
Number of Operating Leases
Number of operating leases.
Current liabilities:
Liabilities, Current [Abstract]
Share-Based Payment Arrangement [Abstract]
Common Stock [Member]
Common Stock
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Investment [Text Block]
Other Investment
Statistical Measurement
Statistical Measurement [Domain]
Other Paragon Research Programs
Other Paragon Research Programs [Member]
Other paragon research programs.
Nonoperating Income (Expense) [Abstract]
Other income:
Director [Member]
Director
Equity, Attributable to Parent [Abstract]
Stockholders' equity (deficit):
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Basic, Total
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic
Weighted Average Shares Outstanding, Basic
Property, Plant and Equipment [Abstract]
Assets [Abstract]
Assets
Entity Central Index Key
Entity Central Index Key
Lessee, Operating Lease, Remaining Lease Term
Remaining lease term
Antidilutive Securities
Antidilutive Securities [Axis]
Aggregate Intrinsic Value, Exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Nature of Business
Class of Stock [Line Items]
Issuance of common stock to former shareholders of Cyclerion in connection with the closing of the reverse recapitalization (in shares)
Stock Issued During Period, Shares, Acquisitions
Consolidation Items [Axis]
Current Fiscal Year End Date
Current Fiscal Year End Date
Class of Warrant or Right [Domain]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Number of Shares
Document Quarterly Report
Document Quarterly Report
Earnings Per Share, Diluted, by Common Class, Including Two-Class Method [Table]
Entity Address, Address Line Three
Net Income (Loss) Available to Common Stockholders, Diluted
Net Income (Loss) Available to Common Stockholders, Diluted, Total
Loss Allocation, Diluted
License option exercise fee
License Option Exercise Fee
License option exercise fee.
Cash and Cash Equivalents
Cash and Cash Equivalents [Axis]
Preferred Stock, Voting Rights
Preferred stock voting rights
Level 2
Fair Value, Inputs, Level 2 [Member]
Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent
Cash
Outstanding at beginning of the year (in dollars per share)
Outstanding at end of the year (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Weighted average exercise price
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Net cash used in operating activities
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Earnings Per Share, Diluted
Total gain (loss) per share
Net loss per share attributable to common stockholders, diluted
Loss Per Share - Diluted
Classification of Convertible Preferred Shares
Stockholders' Equity, Policy [Policy Text Block]
Preferred Stock, Par or Stated Value Per Share
Preferred stock, par value (in dollars per share)
Net loss
Net loss
Loss Allocation
Fair Value Adjustment of Warrants
Fair value of the warrant obligation
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Long-Lived Tangible Asset
Long-Lived Tangible Asset [Domain]
Milestone Payment Reduction Percentage
Milestone payment reduction percentage.
Percentage of milestone payment reduction
Issuance of Common Stock and Pre-funded Warrants in Pre-closing Financing Value
Issuance of common stock and pre-funded warrants in pre-closing financing value.
Issuance of common stock and pre-funded warrants in the Pre-Closing Financing
License Agreements [Text Block]
The entire disclosure for license agreements.
Option/License Agreement
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Net loss and comprehensive loss
Preferred Stock, Liquidation Preference, Value
Preferred stock, liquidation preference value
Measurement Frequency
Measurement Frequency [Domain]
Cash Acquired in Connection with the Reverse Recapitalization
Cash acquired in connection with the reverse recapitalization.
Cash acquired in connection with the reverse recapitalization
Equity Components
Equity Components [Axis]
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Payments to Acquire in Process Research and Development
Payment of additional development materials
Related Party Amount Included in Accounts Payable
Related party amount included in accounts payable.
Related party amount included in accounts payable
Collaborative Arrangement Disclosure [Text Block]
Paragon Agreements
Statement of Cash Flows [Abstract]
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Domain]
Income Tax Disclosure [Abstract]
2026 Parasa Warrant Obligation
Two Thousand Twenty Six Parasa Warrant Obligation [Member]
2026 parasa warrant obligation.
Stockholders' Equity, Reverse Stock Split
Reverse stock split
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted average grant date fair value
Paragon Platform Option Agreement [Member]
Paragon platform option agreement.
Paragon Platform Option Agreement
Patent License Agreement [Member]
Patent license agreement.
Patent License Agreement [Member]
Fair Value Disclosures [Text Block]
Fair Value Measurements
Parasa Warrant Obligation [Member]
Parasa warrant obligation.
Parasa Warrant Obligation
Number of Employees in Joint Development Committee
Number of employees in joint development committee.
Number of employees in joint development committee
Chief Executive Officer [Member]
Chief Executive Officer
Preferred Stock, Shares Authorized
Preferred stock, shares authorized
Mergers, Acquisitions and Dispositions Disclosures [Text Block]
Reverse Recapitalization and Pre-Closing Financing
Class of Stock [Axis]
Collaborative Arrangements Recorded Expense
Collaborative arrangements recorded expense.
Arrangements recorded expense
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Total shares of common stock reserved
Total anti-dilutive securities
Accrued Liabilities and Other Liabilities [Abstract]
Shares available for grant
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Accounts payable
Increase (Decrease) in Accounts Payable, Trade
Temporary Equity, Shares Outstanding
Beginning balance (in shares)
Ending balance (in shares)
Schedule of Common Stock Outstanding Roll Forward [Table Text Block]
Schedule of common stock reserved for future issuance
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Forfeited (in dollars per share)
Other research and development costs
Other Research and Development Expense
Share-based Compensation Plans
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding at beginning of the year (in shares)
Outstanding at end of the year (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Outstanding stock options
Investments, All Other Investments [Abstract]
Document Type
Document Type
Research initiation fees
Research Initiation Fees
Research initiation fees.
CASH FLOWS FROM OPERATING ACTIVITIES:
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Liabilities and Equity [Abstract]
Liabilities, Convertible Preferred Stock and Stockholders' Equity (Deficit)
Stock Option Valuation
Loss from operations
Operating Income (Loss)
Up Front Payment Received
Up Front Payment Received.
Up front payment received
Segment Reporting [Table]
Entity File Number
Entity File Number
Schedule of Total Remaining Operating Lease Payments
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Location, Statement of Income, Balance [Axis]
Retained Earnings [Member]
Accumulated Deficit
Entity Registrant Name
Entity Registrant Name
Shares, Issued
Common stock shares issued
Accounting Policies [Abstract]
Depreciation
Depreciation, Total
Depreciation expense
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Net loss
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Derivative Liability, Fair Value of Collateral
Estimated fair value of the CVR liability
Milestone Payment
Milestone payment.
Milestone payment
Entity Address, Address Line One
Entity Address, Address Line One
Accrued Expenses and Other Current Liabilities
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]
Weighted Average Remaining Contractual Term (years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]
Discontinued Operations
Exercised (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Proceeds from Issuance or Sale of Equity
Proceeds from issuance of securities
Exercisable (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Total current assets
Assets, Current
Furniture and Fixtures [Member]
Furniture and fixtures
Common Stock, Voting Rights
Common stock voting rights
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value, Recurring and Nonrecurring [Table]
Non Cash Exchange Of Pre Merger Preferred Stock for Common Stock and Pre-funded Warrants
Non cash exchange of pre merger preferred stock for common stock and pre-funded warrants.
Non-cash exchange of Pre-Merger Korsana Series A Preferred Stock for common stock and pre-funded warrants
SeriesA Convertible Preferred Stock [Member]
Series A Convertible Preferred Stock
Series A convertible preferred stock.
Earnings Per Share, Policy [Policy Text Block]
Net Loss per Share Attributable to Common Stockholders
Segments [Axis]
Class of Warrant or Right Exercised
Class of warrant or right exercised.
Pre-funded warrants exercised
Derivatives, Policy [Policy Text Block]
Contingent Value Rights
Non Cash Lease Expense
Non cash lease expense.
Non-cash lease expense
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
Net liabilities assumed
Entity Small Business
Entity Small Business
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Aggregate Intrinsic Value, Vested and expected to vest
Related Party Amount Included In Proceeds from Issuance of Convertible Preferred Stock
Related party amount included in the cash inflow from issuance of preferred stocks.
Related party amount included in proceeds from issuance of convertible preferred stock, net of issuance cost
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Unrecognized compensation cost, options
Forfeited (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Consolidation Items [Domain]
Employee-related Liabilities, Current
Employee-related Liabilities, Current, Total
Accrued employee compensation and benefits
Employer contributions
Defined Benefit Plan, Plan Assets, Contributions by Employer
Earnings Per Share [Abstract]
Net loss per share:
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Schedule of Stock Option Activity
Accrued Liabilities And Other Liabilities [Table]
Accrued Liabilities And Other Liabilities.
Lessee, Operating Lease, Liability, to be Paid, Year Four
2030
Plan Name [Axis]
Loss Allocation, Diluted
Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted
Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted, Total
Equity [Abstract]
Series B Convertible Preferred Stock [Member]
Series B convertible preferred stock.
Series B Convertible Preferred Stock
Equity [Text Block]
Convertible Preferred Stock and Stockholders' Equity (Deficit)
Measurement Frequency
Measurement Frequency [Axis]
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Consolidated Entities
Consolidated Entities [Axis]
Entity Tax Identification Number
Entity Tax Identification Number
Stock Issued During Period, Shares, Conversion of Convertible Securities
Conversion of Convertible Securities, Shares
Equity Component
Equity Component [Domain]
Entity Address, City or Town
Entity Address, City or Town
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic, Total
Loss Allocation, Basic
Stock Issued During Period, Value, New Issues
Gross proceeds
Issuance of Series A convertible preferred stock, net of issuance costs
Segments [Domain]
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Warrant coverage percentage
Percentage of Warrant Coverage Outstanding Capital Stock
Percentage of outstanding capital stock covered by warrants.
Non Refundable Milestone Payments
Non-refundable milestone payments.
Non-refundable milestone payments
Amendment Akebia Research License Agreement [Member]
Amendment Akebia Research License Agreement.
Amendment Akebia Research License Agreement [Member]
Stockholders' Equity Note, Stock Split
Stock conversion terms
Description of term of Contract
Lessee, Operating Lease, Term of Contract, Description
Lessee, operating lease, term of contract, description.
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Antidilutive Security, Excluded EPS Calculation [Table]
Paragon Antibody Discovery and Option Agreement
Paragon Antibody Discovery and Option Agreement [Member]
Paragon antibody discovery and option agreement.
Statement [Table]
Statement [Table]
Software and Software Development Costs [Member]
Computer software
Share-based compensation
Share-Based Payment Arrangement, Expense
Stock-based compensation expense
Options exercised
Collaboration Options Exercised
Collaboration options exercised.
Entity Shell Company
Entity Shell Company
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Expected term (in years)
Accounts Payable and Other Accrued Liabilities, Current
Unpaid expense
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Net cash used in investing activities
Statement [Line Items]
Statement [Line Items]
Number of financing leases
Number Of Financing Leases
Number of financing leases.
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-cash exchange of Pre-Merger Korsana Series Seed Preferred Stock for Series B Non-Voting Convertible Preferred Stock
Non Cash Exchange of Pre Merger Preferred Stock
Non cash exchange of pre merger preferred stock.
Vested (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Vested (in shares)
Maximum
Maximum [Member]
Parasa Holding LLC [Member]
Parasa Holding LLC.
Parasa Holding LLC
Disclosure Text Block Supplement [Abstract]
Reverse Recapitalization and Pre-Closing Financing [Abstract]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Federal statutory rate
Cyclerion
Cyclerion Therapeutics Inc [Member]
Cyclerion Therapeutics Inc.
Granted (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Current assets:
Assets, Current [Abstract]
Accrued Professional Fees, Current
Accrued professional and consulting
Related Party Transaction [Domain]
Leases [Abstract]
Document Fiscal Year Focus
Document Fiscal Year Focus
Common stock, shares outstanding
Beginning balance (in shares)
Ending balance (in shares)
Common Stock, Shares, Outstanding
Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Related Party
Related Party [Member]
Entity Ex Transition Period
Entity Ex Transition Period
All Award Types
Operating Lease, Liability, Noncurrent
Operating lease liability, non-current
Long term lease liabilities
Paragon Antibody Oligo Conjugate Research Letter Agreement [Member]
Paragon antibody oligo conjugate research letter agreement.
Paragon Antibody Oligo Conjugate Research Letter Agreement
Lessee, Operating Lease, Liability, to be Paid
Total undiscounted lease payments
Security Exchange Name
Security Exchange Name
Total revenues
Revenues
Total revenues
Related Party
Related and Nonrelated Parties [Axis]
New Accounting Pronouncements, Policy [Policy Text Block]
Recently Issued Accounting Pronouncement Not Yet Adopted
Class of Warrant or Right, Exercise Price of Warrants or Rights
Exercise price per share
Entity Address, State or Province
Entity Address, State or Province
Expected period to recognize the expense
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Unrecognized compensation cost, recognition period (in years)
Number of Options
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Series A Preferred Stock [Member]
Series A Convertible Preferred Stock
Series A Preferred Stock
Initial shares authorized
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
License agreement expiration terms
Collaborative Arrangement, Rights and Obligations
Operating Lease, Right-of-Use Asset
Operating lease right-of-use asset
Option additional fee
Option additional fee.
Option Additional Fee
Amendment Flag
Amendment Flag
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Operating lease liability arising from obtaining right-of-use asset
Share-Based Payment Arrangement [Text Block]
Stock-Based Compensation
Fairmount [Member]
Fairmount.
Fairmount
Total cash, cash equivalents and restricted cash
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
City Area Code
City Area Code
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Schedule of fair value hierarchy for financial assets and liabilities measured
Features of Convertible Preferred Stock [Abstract]
Convertible preferred stock:
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Paragon Agreements
Restricted Stock Awards (RSA)
Restricted Stock Awards [Member]
Restricted stock awards.
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Liabilities
Business combination recognized identifiable assets acquired And liabilities assumed accrued liabilities.
Accrued expenses
Cash, Cash Equivalents, and Restricted Cash
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
Operating Expenses [Abstract]
Operating expenses:
Development Milestone Payment
Development milestone payment.
Development milestone payment
Paragon ADOA [Member]
Paragon ADOA.
Paragon ADOA
Common stock, par value (in dollars per share)
Common Stock, Par or Stated Value Per Share
Cash equivalents:
Cash and Cash Equivalents [Abstract]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Weighted Average Remaining Contractual Term (years), Exercisable
Lessee, Leases [Policy Text Block]
Leases
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Vested and expected to vest, (in shares)
2025 Equity Incentive Plan
Two Thousand Twenty Five Equity Incentive Plan [Member]
2025 equity incentive plan.
Total current liabilities
Liabilities, Current
Leasehold improvements
Leasehold Improvements [Member]
Segment Reporting
Segment Reporting [Text Block]
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Trading Symbol
Trading Symbol
Property, Plant and Equipment [Table Text Block]
Schedule of Property and Equipment, Net
Proceeds from Issuance of Convertible Preferred Stock
Proceeds from issuance of convertible preferred stock, net of issuance cost
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Granted (in shares)
Entity Emerging Growth Company
Entity Emerging Growth Company
Additional Paid-in Capital [Member]
Additional Paid-in Capital
Plan Name [Domain]
Issuance of Common Stock and Pre-funded Warrants in Pre-closing Financing
Issuance of common stock and pre-funded warrants in pre-closing financing.
Issuance of common stock and pre-funded warrants in the Pre-Closing Financing (in shares)
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Supplemental disclosure of non-cash financing activities:
Cover [Abstract]
Schedule of Cash and Cash Equivalents [Table Text Block]
Cash, Cash Equivalents, and Restricted Cash
Collaborative Arrangement, Payment For One Time Fee
Collaborative arrangement, payment for one time fee.
Collaborative arrangement, payment for one time fee
Certificate of Designation
Certificate of Designation [Member]
Certificate of designation.
Insurance Recoveries
Insurance Recoveries
Nonvested Restricted Stock Shares Activity [Table Text Block]
Summary of RSA activity
Estimated useful life
Property, Plant, and Equipment, Useful Life
Share-based Payment Arrangement, Noncash Expense, Total
Share-based compensation expense
Share-Based Payment Arrangement, Noncash Expense
Additional Paid in Capital
Additional paid-in capital
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities:
Fair Value Disclosures [Abstract]
Cash and Cash Equivalents, at Carrying Value, Ending Balance
Cash and Cash Equivalents, at Carrying Value, Beginning Balance
Cash and Cash Equivalents, at Carrying Value, Total
Cash and cash equivalents
Cash and Cash Equivalent
Accrued Expenses And Other Current Liabilities Includes Related Party Amount
Accrued expenses and other current liabilities includes related party amount
Related party under accrued expenses and other current liabilities
Net cash provided by financing activities
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Discontinued Operations and Disposal Groups [Abstract]
Akebia Supply Agreement [Member]
Akebia Supply Agreement.
Akebia Supply Agreement [Member]
Series Seed Preferred Stock [Member]
Series seed preferred stock.
Series Seed Preferred Stock
Loss Allocation, Basic
Net Income (Loss) Available to Common Stockholders, Basic
Net Income (Loss) Available to Common Stockholders, Basic, Total
Cancelled or forfeited (in shares)
Stock options forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Vested options, cancelled
Entity Filer Category
Entity Filer Category
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Vested and expected to vest (in dollars per share)
Preferred Stock, Convertible, Conversion Ratio
Preferred stock conversion ratio
Property and equipment, net
Property and equipment, net
Property, Plant and Equipment, Net, Ending Balance
Property, Plant and Equipment, Net, Beginning Balance
Property, Plant and Equipment, Net
Ending balance (in shares)
Beginning balance (in shares)
Shares, Outstanding
Segment Reporting [Abstract]
Payments for Repurchase of Private Placement
Aggregate purchase price
Purchases of property and equipment included in accounts payable and accrued expenses
Purchases of Property and Equipment Included in Accounts Payable and Accrued Expenses
Purchases of property and equipment included in accounts payable and accrued expenses.
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Statement of Financial Position [Abstract]
Paragon [Member]
Paragon.
Paragon
Local Phone Number
Local Phone Number